航空航天医学杂志
航空航天醫學雜誌
항공항천의학잡지
AEROSPACE MEDICINE
2014年
8期
1049-1051
,共3页
APACHE II评分%动脉血乳酸%血清降钙素原%重症肺炎%预后
APACHE II評分%動脈血乳痠%血清降鈣素原%重癥肺炎%預後
APACHE II평분%동맥혈유산%혈청강개소원%중증폐염%예후
APACHE II%Arterial Blood Lactate%Serum Procalcitonin%Severe Pneumonia%Prognosis
目的:探讨APACHE II评分、动脉血乳酸、血清降钙素原与重症肺炎预后之间的关系。方法分析2011~2013年住院82例重症肺炎的病例资料,统计出院时的死亡率、存活率,并根据患者存活与否将其分为存活组和死亡组,观察两组患者组间及组内APACHEII评分、动脉血乳酸、血清降钙素原的动态变化。结果出院时重症肺炎患者的存活率为59.76%,死亡率为40.24%。存活组患者确诊重症肺炎时的APACHE II评分、动脉血乳酸、血清降钙素原分别为(21.85±6.50分)、(3.81±2.43 mmol/L)、(3.68±3.09 ng/mL),而死亡组分别为(25.24±7.15分)、(5.42±3.76 mmol/L)、(5.48±4.15 ng/mL),三者组间比较均有显著性差异(P<0.05);存活组患者APACHE II评分、动脉血乳酸、血清降钙素原随住院天数的增加而降低,死亡组患者相反。 APACHE II评分与动脉血乳酸、血清降钙素原呈正相关。存活组、死亡组治疗第3、7天后三组间相比,APACHE II评分、动脉血乳酸、血清降钙素原均具有显著性差异( P<0.05)。结论重症肺炎治疗后的APACHE II评分及动脉血乳酸、血清降钙素原的动态变化情况,可作为患者病情及预后判断的参考之一。
目的:探討APACHE II評分、動脈血乳痠、血清降鈣素原與重癥肺炎預後之間的關繫。方法分析2011~2013年住院82例重癥肺炎的病例資料,統計齣院時的死亡率、存活率,併根據患者存活與否將其分為存活組和死亡組,觀察兩組患者組間及組內APACHEII評分、動脈血乳痠、血清降鈣素原的動態變化。結果齣院時重癥肺炎患者的存活率為59.76%,死亡率為40.24%。存活組患者確診重癥肺炎時的APACHE II評分、動脈血乳痠、血清降鈣素原分彆為(21.85±6.50分)、(3.81±2.43 mmol/L)、(3.68±3.09 ng/mL),而死亡組分彆為(25.24±7.15分)、(5.42±3.76 mmol/L)、(5.48±4.15 ng/mL),三者組間比較均有顯著性差異(P<0.05);存活組患者APACHE II評分、動脈血乳痠、血清降鈣素原隨住院天數的增加而降低,死亡組患者相反。 APACHE II評分與動脈血乳痠、血清降鈣素原呈正相關。存活組、死亡組治療第3、7天後三組間相比,APACHE II評分、動脈血乳痠、血清降鈣素原均具有顯著性差異( P<0.05)。結論重癥肺炎治療後的APACHE II評分及動脈血乳痠、血清降鈣素原的動態變化情況,可作為患者病情及預後判斷的參攷之一。
목적:탐토APACHE II평분、동맥혈유산、혈청강개소원여중증폐염예후지간적관계。방법분석2011~2013년주원82례중증폐염적병례자료,통계출원시적사망솔、존활솔,병근거환자존활여부장기분위존활조화사망조,관찰량조환자조간급조내APACHEII평분、동맥혈유산、혈청강개소원적동태변화。결과출원시중증폐염환자적존활솔위59.76%,사망솔위40.24%。존활조환자학진중증폐염시적APACHE II평분、동맥혈유산、혈청강개소원분별위(21.85±6.50분)、(3.81±2.43 mmol/L)、(3.68±3.09 ng/mL),이사망조분별위(25.24±7.15분)、(5.42±3.76 mmol/L)、(5.48±4.15 ng/mL),삼자조간비교균유현저성차이(P<0.05);존활조환자APACHE II평분、동맥혈유산、혈청강개소원수주원천수적증가이강저,사망조환자상반。 APACHE II평분여동맥혈유산、혈청강개소원정정상관。존활조、사망조치료제3、7천후삼조간상비,APACHE II평분、동맥혈유산、혈청강개소원균구유현저성차이( P<0.05)。결론중증폐염치료후적APACHE II평분급동맥혈유산、혈청강개소원적동태변화정황,가작위환자병정급예후판단적삼고지일。
Objective To investigate correlation between the APACHE II score , arterial blood lactate , serum procal-citonin and prognosis of severe pneumonia.Methods The clinical data of 82 patients with severe pneumonia from 2011 to 2013 were retrospectively analyzed in our hospital.Mortality and survival at discharge were collected.We divided all the patients into two groups according to whether the patients is alive and observed the dynamic change of APACHE II score, arterial blood lactate, serum procalcitonin.Results The survival mortality of severe pneumonia patients at dis-charge were 59.76%and 40.24%.APACHE II score, arterial blood lactate, serum procalcitonin in survival group were (21.85 ±6.50 points), (3.81 ±2.43 mmol/L), (3.68 ±3.09 ng/mL), and were (25.24 ±7.15 points), (5.42 ± 3.76 mmol/L), (5.48 ±4.15 ng/mL) in death group respectively.Significant differences (P<0.05) were found a-mong three groups of data.All data decreased with increasing days of hospitalization in survival groups while the trend was exactly the opposite in death group.APACHE II was positively correlated with arterial blood lactate and serum pro-calcitonin.There are significant differences in three groups of data between the survival group and death group on the third day as well as on the seventh day.Conclusions The dynamic change of APACHE II score , arterial blood lactate , and serum procalcitonin can be one of the references to evaluate the condition and prognosis of patients .